Effect of race on thyroid cancer care in an equal access healthcare system

American Journal of Surgery

Volumn 199, Issue 5, 2010, Pages 685-689

  Brown, Shaun R ^a   Lee, Sukhyung ^a   Brown, Tommy A ^b   Waddell, Brad E ^a  

^a WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Ethnic; Racial; Screening; Thyroid cancer

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CAUCASIAN; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; THYROID SURGERY;

ADULT; AFRICAN AMERICANS; BIOPSY, NEEDLE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TEXAS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 77951893869     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.01.020     Document Type: Article

References (17)

1. Miller B.A., Bernstein L., et al. Racial/ethnic patterns of cancer in the United States 1988-92. KL (1996), NIH publication no. 96, Bethesda, MD
2. Hardy D., Liu C.C., Xia R., et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 115 (2009) 2199-2211
3. Ward E., Jemal A., Cokkinides V., et al. Cancer disparities by race/ethnicity and socioeconomic status. A Cancer J Forest Clin 54 (2004) 78-93
4. Freedman R.A., He Y., Winer E.P., et al. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27 (2009) 713-719
5. Morris L.G., Sikora A.G., Myssiorek D., et al. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol 15 (2008) 1169-1176
6. Albain K.S., Unger J.M., Crowley J.J., et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101 (2009) 984-992
7. Epidemiology and End Results (SEER) program (http://www.seer.cancer.gov). SEER*Stat database: populations-total U.S. (1969-2006) -linked to county attributes-total U.S., 1,969-2,006 counties. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2009.
8. Chen A.Y., Jemal A., and Ward E.M. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115 (2009) 3801-3807
9. Mitchell I., Livingston E.H., Chang A.Y., et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 142 (2007) 823-828
10. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 (2006) 2164-2167
11. Liebeskind A., Sikora A.G., Komisar A., et al. Rates of malignancy in incidentally discovered thyroid nodules evaluated with sonography and fine-needle aspiration. J Ultrasound Med 24 (2005) 629-634
12. Terplan M., Smith E.J., and Temkin S.M. Race in ovarian cancer treatment and survival: a systematic review with meta-analysis. Cancer Causes Control 20 (2009) 1139-1150
13. Elias E.G., Suter C.M., Brown S.D., et al. Survival differences between black and white women with breast cancer. J Surg Oncol 55 (1994) 37-41
14. Yan B., Noone A.M., Yee C., et al. Racial differences in colorectal cancer survival in the Detroit metropolitan area. Cancer 115 (2009) 3791-3800
15. Sakorafas G.H., Sampanis D., and Safioleas M. Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol (2009) in press
16. Mosley E.L., Chung E.B., Rogers N., et al. Thyroid carcinoma in black patients. J Natl Med Assoc 70 (1978) 915-918
17. Zhu K., Devesa S.S., Wu H., et al. Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev 18 (2009) 1740-1745